These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 34014337)

  • 1. Predictors for a high apixaban level in elderly patients with atrial fibrillation prescribed reduced dose of apixaban.
    Suzuki S; Yamashita T; Akao M; Okumura K
    Eur J Clin Pharmacol; 2021 Nov; 77(11):1757-1758. PubMed ID: 34014337
    [No Abstract]   [Full Text] [Related]  

  • 2. Characteristics of Apixaban-Treated Patients, Evaluation of the Dose Prescribed, and the Persistence of Treatment: A Cohort Study in Catalonia.
    Gomez-Lumbreras A; Cortes J; Giner-Soriano M; Quijada-Manuitt MA; Morros R
    J Cardiovasc Pharmacol Ther; 2018 Nov; 23(6):494-501. PubMed ID: 29792125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acquired Hemophilia A in an Elderly Patient on Apixaban Therapy.
    Skorochod R; Applbaum Y; Nesher G; Tvito A
    Isr Med Assoc J; 2021 Feb; 23(2):130-131. PubMed ID: 33595223
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of direct oral anticoagulants in very elderly patients: a case report of apixaban in an ultracentenary patient.
    Manno G; Novo G; Corrado E; Coppola G; Novo S
    J Cardiovasc Med (Hagerstown); 2019 Jun; 20(6):403-405. PubMed ID: 30762659
    [No Abstract]   [Full Text] [Related]  

  • 5. Initial apixaban dosing in patients with atrial fibrillation.
    Buchholz A; Ueberham L; Gorczynska K; Dinov B; Hilbert S; Dagres N; Husser D; Hindricks G; Bollmann A
    Clin Cardiol; 2018 May; 41(5):671-676. PubMed ID: 29542830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apixaban for prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation in France: The PAROS cross-sectional study of routine clinical practice.
    Falissard B; Picard F; Mahe I; Hanon O; Touzé E; Danchin N; Lamy FX; Ricci L; Steg PG
    Arch Cardiovasc Dis; 2019; 112(6-7):400-409. PubMed ID: 31014991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicenter prospective cohort study to investigate the effectiveness and safety of apixaban in Japanese elderly atrial fibrillation patients (J-ELD AF Registry).
    Okumura K; Yamashita T; Suzuki S; Akao M;
    Clin Cardiol; 2020 Mar; 43(3):251-259. PubMed ID: 31737921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Xa Activity in Elderly Xabans-Treated Patients With Atrial Fibrillation.
    Samoš M; Bolek T; Škorňová I; Stančiaková L; Urban L; Staško J; Galajda P; Kubisz P; Mokáň M
    Am J Ther; 2020; 27(5):e507-e509. PubMed ID: 31356346
    [No Abstract]   [Full Text] [Related]  

  • 9. A rare side effect seen due to the use of apixaban: Palmoplantar psoriasiform drug eruption.
    Veliyev V; Özmen İ; Yaşar S; Gürsoy E; Köklü M; Çelik M
    Anatol J Cardiol; 2016 Mar; 16(3):213-5. PubMed ID: 27067558
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of apixaban on antifactor Xa levels in a patient with acute kidney injury.
    Wendte J; Voss G; VanOverschelde B
    Am J Health Syst Pharm; 2016 Apr; 73(8):563-7. PubMed ID: 27045068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population Pharmacokinetics of Apixaban in Subjects With Nonvalvular Atrial Fibrillation.
    Cirincione B; Kowalski K; Nielsen J; Roy A; Thanneer N; Byon W; Boyd R; Wang X; Leil T; LaCreta F; Ueno T; Oishi M; Frost C
    CPT Pharmacometrics Syst Pharmacol; 2018 Nov; 7(11):728-738. PubMed ID: 30259707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population pharmacokinetics and pharmacogenomics of apixaban in Japanese adult patients with atrial fibrillation.
    Ueshima S; Hira D; Kimura Y; Fujii R; Tomitsuka C; Yamane T; Tabuchi Y; Ozawa T; Itoh H; Ohno S; Horie M; Terada T; Katsura T
    Br J Clin Pharmacol; 2018 Jun; 84(6):1301-1312. PubMed ID: 29457840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-World Rivaroxaban and Apixaban Levels in Asian Patients With Atrial Fibrillation.
    Lin SY; Kuo CH; Yeh SJ; Tsai LK; Liu YB; Huang CF; Tang SC; Jeng JS
    Clin Pharmacol Ther; 2020 Jan; 107(1):278-286. PubMed ID: 31376150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial.
    Halvorsen S; Atar D; Yang H; De Caterina R; Erol C; Garcia D; Granger CB; Hanna M; Held C; Husted S; Hylek EM; Jansky P; Lopes RD; Ruzyllo W; Thomas L; Wallentin L
    Eur Heart J; 2014 Jul; 35(28):1864-72. PubMed ID: 24561548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stroke and Bleeding Risks in Patients with Atrial Fibrillation Treated with Reduced Apixaban Dose: A Real-Life Study.
    Salameh M; Gronich N; Stein N; Kotler A; Rennert G; Auriel E; Saliba W
    Clin Pharmacol Ther; 2020 Dec; 108(6):1265-1273. PubMed ID: 32558928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety outcomes of apixaban in patients with nonvalvular atrial fibrillation and severe renal impairment.
    Jones MJ; Eudaley ST; Moye RA; Hodge TA; Nesbit RM; Franks AS
    J Thromb Thrombolysis; 2020 Aug; 50(2):330-336. PubMed ID: 31902123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Advances in Atrial Fibrillation Management: The Role of Apixaban.
    Rosano GMC; Spoletini I; Gianni W; Vitale C
    Curr Drug Targets; 2018; 19(6):585-592. PubMed ID: 29034832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Major bleeding with apixaban in atrial fibrillation: patient characteristics, management, and outcomes.
    Eisho S; Salem NM; Hoffman JL; Koerber JM; Smythe MA
    Hosp Pract (1995); 2018 Oct; 46(4):165-169. PubMed ID: 30058431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary stroke prevention with apixaban in nonvalvular atrial fibrillation: A subgroup analysis of the STANDARD study.
    Yasaka M; Umeyama M; Kataoka H; Inoue H
    J Stroke Cerebrovasc Dis; 2020 Sep; 29(9):105034. PubMed ID: 32807446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quick reference guide to apixaban.
    Hurst KV; O'Callaghan JM; Handa A
    Vasc Health Risk Manag; 2017; 13():263-267. PubMed ID: 28744136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.